EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells

Wiktoria Monika Piskorz iD, Rafał Krętowski, Marzanna Cechowska-Pasko iD

Molecules · 2024

DOI: 10.3390/molecules29235652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Wiktoria Monika Piskorz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222 Białystok, Poland. Hauptthemen laut MEDLINE: Cellular Senescence, Melanoma, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence is cell cycle arrest and the inhibition of cell proliferation. New anticancer approaches include the elimination of cancer cells through the induction of senescence followed by senolysis. New prosenescence compounds are still being searched for. Little is known about the ability of proteasome inhibitors to induce senescence in tumor cells, especially in malignant melanoma. The aim of our study was to verify the activity of a natural proteasome inhibitor—marizomib (MZB)—directly after incubation and after its removal to assess its potential to induce senescence or long-term apoptosis in malignant melanoma cell lines (A375 and G361). After 48 h of incubation with MZB, we observed an increased number of SA-β-galactosidase-positive cells, upregulated expression of P21 and P-P53 proteins and an increased number of cells at the subG1 phase (line G361) or at both the subG1 and G2/M phases (line A375). After 96 h from inhibitor removal, the G361 line presented signs of senescence (increased level of SA-β-galactosidase, IL-8, P-P53, G2/M and S phases of cell cycle, decreased lamin B1 and cleaved lamin B1), while the A375 line demonstrated more signs of apoptosis (increased subG1 phase, P-P53, cleaved lamin B1). The gathered findings suggest that MZB resulted in the induction of cellular senescence (line G361) or enhanced apoptosis (line A375) in the melanoma cell lines tested here and could be a promising therapeutic factor in malignant melanoma treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceMelanomaApoptosisHumansCell Line, TumorCell ProliferationTumor Suppressor Protein p53Antineoplastic AgentsCell Cycle CheckpointsCell CycleLactones

Stichwörter der Autor:innen

NPI-0052apoptosiscancer treatmentproteasome inhibitionsalinosporamide Asenescence

Substanzen

Tumor Suppressor Protein p53Antineoplastic AgentsLactones

Autor:innen und Institutionen

  • Department of Pharmaceutical Biochemistry, Medical University of Bialystok, Mickiewicza 2A, 15-222 Białystok, Poland.

ORCID-Profile: Wiktoria Monika Piskorz, Marzanna Cechowska-Pasko

Förderung

  • Medical University of Bialystok

Zitieren

APA

Piskorz, W. M., Krętowski, R., & Cechowska-Pasko, M. (2024). Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells. Molecules. https://doi.org/10.3390/molecules29235652

Vancouver

Piskorz WM, Krętowski R, Cechowska-Pasko M. Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells. Molecules. 2024. doi:10.3390/molecules29235652

BibTeX
@article{Piskorz2024,
  author = {Piskorz, Wiktoria Monika and Krętowski, Rafał and Cechowska-Pasko, Marzanna},
  title = {Marizomib Promotes Senescence or Long-Term Apoptosis in Melanoma Cancer Cells},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29235652}
}
Kostenlos starten →